Lanean...
An Adaptive Multi-Stage Phase I Dose-finding Design Incorporating Continuous Efficacy and Toxicity Data from Multiple Treatment Cycles
Phase I designs traditionally use the dose-limiting toxicity (DLT), a binary endpoint from the first treatment cycle, to identify the maximum-tolerated dose (MTD) assuming a monotonically increasing relationship between dose and efficacy. In this article, we establish a general framework for a multi...
Gorde:
| Argitaratua izan da: | J Biopharm Stat |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6379115/ https://ncbi.nlm.nih.gov/pubmed/30403559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2018.1535497 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|